Regulating pharmaceutical prices in India : (Record no. 29296)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02104nam a2200253Ia 4500 |
| 001 - CONTROL NUMBER | |
| control field | 38204 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | IN-BdCUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20230421155021.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 230413s2023 000 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3319933922 |
| 040 ## - CATALOGING SOURCE | |
| Language of cataloging | eng |
| Transcribing agency | IN-BdCUP |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 338.473621 |
| Item number | BHA |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bhaskarabhatla, Ajay |
| 245 #0 - TITLE STATEMENT | |
| Title | Regulating pharmaceutical prices in India : |
| Remainder of title | Policy design, implementation and compliance / |
| Statement of responsibility, etc. | Bhaskarabhatla, Ajay |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Rotterdam : |
| Name of publisher, distributor, etc. | Springer, |
| Date of publication, distribution, etc. | 2018. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | ix, 306 p. ; |
| Dimensions | 22 cm. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India's 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Business & Economics |
| Topical term or geographic name entry element | Pharmaceutical prices in India |
| Topical term or geographic name entry element | Policy design |
| Topical term or geographic name entry element | Business and economics |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Book |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Source of acquisition | Cost, normal purchase price | Bill number | Total checkouts | Full call number | Barcode | Date last seen | Actual Cost, replacement price | Bill Date | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Ranganathan Library | Ranganathan Library | 11/07/2019 | International Book Distributor, New Delhi | 8876.19 | 113524 | 338.473621 BHA | 037163 | 13/04/2023 | 5769.52 | 14/03/2019 | Book |